Mosapride as a hepatic CYP3A probe in rats: application to rivaroxaban pharmacokinetics
碩士 === 國立成功大學 === 藥理學研究所 === 101 === Introduction Rivaroxaban, an oral, direct, specific inhibitor of factor Xa, is indicated for the prophylaxis of deep vein thrombosis. About two-thirds of the administered dose of rivaroxaban undergoes metabolic degradation. CYP3A isozymes, one of the most imp...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | zh-TW |
| Published: |
2013
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/v86m9j |